Divi's Laboratories

Divi's Laboratories Net Margin

The Net Profit Margin of Divi's Laboratories (DIVISLAB.NS) as of Oct 10, 2026 is 23.41 %. In the previous year, Net Profit Margin was 20.40 % — a change of 14.77% (higher).

Net Margin

23.41 %

YoY

14.77%

Last updated:

Net Profit Margin of Divi's Laboratories is 2025 23.41 % . Net Profit Margin of Divi's Laboratories was 2024 20.40 % . It decreases by 14.77% higher compared to the previous year.

For Divi's Laboratories, the net margin of 23.4% is down versus 28.5% a few years ago.

The Divi's Laboratories Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
22.41 INR
Jan 1, 2019
27.35 INR
Jan 1, 2020
25.52 INR
Jan 1, 2021
28.47 INR
Jan 1, 2022
33.04 INR
Jan 1, 2023
23.47 INR
Jan 1, 2024
20.40 INR
Jan 1, 2025
23.41 INR
The Divi's Laboratories Net Margin history
YEARNet MarginYoY
23.41 %+14.77%
20.40 %-13.12%
23.47 %-28.95%
33.04 %+16.05%
28.47 %+11.57%
25.52 %-6.69%
27.35 %+22.02%
22.41 %-13.21%
25.82 %-12.72%
29.59 %+7.88%
27.43 %-10.39%
30.61 %+10,804.36%
0.28 %-1.90%
0.29 %-12.26%
0.33 %-9.77%
0.36 %+2.39%
0.35 %+4.87%
0.34 %+31.18%
0.26 %+40.68%
0.18 %—
Access this data via the Eulerpool API

Divi's Laboratories Stock analysis

What does Divi's Laboratories do? Divi's Laboratories Ltd. is a pharmaceutical company based in Hyderabad, India. It was founded in 1990 and has become one of the leading manufacturers of active ingredients and formulations for the pharmaceutical industry in recent years. The company was founded by Dr. Murali Divi, who built the company on principles of quality, technology, and innovation. Divi's Laboratories now employs approximately 13,000 employees and operates production facilities in India and the USA. The company operates in various sectors, including generics, custom synthesis, research and development, and nutraceuticals. Its products are used worldwide and are approved in over 95 countries. Divi's Laboratories follows a vertically integrated supply chain model, producing high-quality active ingredients and developing its own formulations for the pharmaceutical industry. The company always relies on innovative technologies and continuous improvement of product quality. Its product range includes a wide range of active ingredients for various therapeutic areas, such as antibiotics, antidepressants, antihypertensives, antidiabetics, static lipid-lowering agents, and antipsychotics. Divi's Laboratories has state-of-the-art production facilities, strict quality controls, and advanced analytical facilities for all pharmaceutical ingredients. In addition to its active ingredients, the company is also known for its custom synthesis services, which involve the production of customer-specific active ingredients for the pharmaceutical industry. Divi's Laboratories offers a tailored service that meets the specific requirements of customers, ranging from the development of new active ingredients and formulations to the production of small or medium quantities of active ingredients. In the area of research and development, Divi's Laboratories works closely with academic institutions and other pharmaceutical companies to leverage the latest scientific knowledge and develop innovative products. The company invests a significant sum in research and development annually. In addition to active ingredients and custom synthesis services, Divi's Laboratories also offers a range of nutraceuticals. These products, such as vitamins, minerals, and other dietary supplements, are used to support a healthy lifestyle. In summary, Divi's Laboratories is an India-based pharmaceutical company specializing in the manufacture of active ingredients and formulations for the pharmaceutical industry. The company operates to the highest quality standards and relies on innovative technologies and sustainable product development. The wide product range and custom synthesis services offer customers a tailored solution for their needs. Divi's Laboratories is a leading provider of active ingredients and has made a name for itself in the pharmaceutical and nutraceutical industry due to its high quality and productivity. Divi's Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Divi's Laboratories stock

Net Profit Margin of Divi's Laboratories is 23.41 % in 2025.

Net Profit Margin of Divi's Laboratories changed from 20.40 % to 23.41 %, representing a 14.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Divi's Laboratories since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Divi's Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Divi's Laboratories

All Key Metrics — Divi's Laboratories